Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Clinical trial NCT05260671 · RECRUITING

Trial details

NCT number: NCT05260671
Sponsor: Eye & ENT Hospital of Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms Recurrent Disease Metastatic Cancer

Start date: 2022-01-25
Primary completion: 2024-12-25
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.